Brief: Neurizon Files Ind Application To Support Healey Als Platform Trial
18/12/2024 12:38
Dec 18 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX :
* NEURIZON FILES IND APPLICATION TO SUPPORT HEALEY ALS
PLATFORM
TRIAL
Source text: ID:nPnbYcrBsa
Further company coverage: NUZ.AX
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility